Shots:

• Quidel to acquire Ortho Clinical Diagnostics for $24.68/share of common stock making a total equity value of $6.0B including $1.75B in cash & assume $2.0B in net debt representing a premium of 25% over Ortho’s closing price on Dec 22, 2021. The transaction is expected to close in H1’22
• The acquisition will boost Quidel’s global leadership in diagnostics by combining diagnostic portfolios with technologies & platforms that help to advance diagnostic solutions to improve patient outcomes & offers economic benefits to the healthcare system
• Ortho will receive $7.14 in cash & 0.1055 shares of common stock in the combined company for Ortho common share & is expected ~38% of a combined company

Ref: Quidel | Image: Ortho Clinical